454
Participants
Start Date
December 20, 2021
Primary Completion Date
December 31, 2024
Study Completion Date
July 31, 2025
chiauranib
50mg orally once daily
Placebo
50mg orally once daily
Paclitaxel
at the first cycle, 60mg/m2, i.v infusion on day 1, 8 and 15 ; at the begining of the second cycle, after a comprehensive assessment , investigators decide whether to increase the dosage to 80mg/m2, i.v infusion on day 1, 8 and 15 ;
RECRUITING
Fudan University Shanghai Cancer Center, Shanghai
Lead Sponsor
Chipscreen Biosciences, Ltd.
INDUSTRY